Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update
TJ Smith, K Bohlke, GH Lyman, KR Carson… - Journal of Clinical …, 2015 - ascopubs.org
Purpose To update the 2006 American Society of Clinical Oncology guideline on the use of
hematopoietic colony-stimulating factors (CSFs). Methods The American Society of Clinical …
hematopoietic colony-stimulating factors (CSFs). Methods The American Society of Clinical …
Scales to assess the quality of randomized controlled trials: a systematic review
Background and Purpose The methodological quality of randomized controlled trials (RCTs)
is commonly evaluated in order to assess the risk of biased estimates of treatment effects …
is commonly evaluated in order to assess the risk of biased estimates of treatment effects …
Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective
M Tomblyn, T Chiller, H Einsele, R Gress… - Bone marrow …, 2009 - nature.com
Guidelines for preventing infectious complications among hematopoietic cell transplant
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …
recipients: a global perspective | Bone Marrow Transplantation Skip to main content Thank you …
There was evidence of convergent and construct validity of Physiotherapy Evidence Database quality scale for physiotherapy trials
OBJECTIVE: To evaluate the convergent and construct validity of the Physiotherapy
Evidence Database (PEDro) scale used to rate the methodological quality of randomized …
Evidence Database (PEDro) scale used to rate the methodological quality of randomized …
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable …
V Gupta, MS Tallman, W He, BR Logan… - Blood, The Journal …, 2010 - ashpublications.org
We compared the outcomes of unrelated donor (URD, n= 358) with human leukocyte
antigen (HLA)–matched sibling donor (MSD, n= 226) transplantations in patients with acute …
antigen (HLA)–matched sibling donor (MSD, n= 226) transplantations in patients with acute …
Escalas y listas de evaluación de la calidad de estudios científicos
FC da Silva, BAV Arancibia… - Revista Cubana de …, 2013 - medigraphic.com
El objetivo de este estudio fue identificar las escalas de evaluación de la calidad
metodológica de artículos científicos y de las listas de verificación de la calidad de …
metodológica de artículos científicos y de las listas de verificación de la calidad de …
Mucosal barrier injury, fever and infection in neutropenic patients with cancer: introducing the paradigm febrile mucositis
WJFM van der Velden, AHE Herbers… - British journal of …, 2014 - Wiley Online Library
Infection remains one of the most prominent complications after cytotoxic treatment for
cancer. The connection between neutropenia and both infections and fever has long been …
cancer. The connection between neutropenia and both infections and fever has long been …
Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection
Background: Benefits of prophylactic hematopoietic colony-stimulating factors (CSFs) in
adults and children receiving cancer chemotherapy or undergoing stem-cell transplantation …
adults and children receiving cancer chemotherapy or undergoing stem-cell transplantation …
Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF–licensed myeloid cells
S Tugues, A Amorim, S Spath… - Science translational …, 2018 - science.org
Allogeneic hematopoietic cell transplantation (allo-HCT) not only is an effective treatment for
several hematologic malignancies but can also result in potentially life-threatening graft …
several hematologic malignancies but can also result in potentially life-threatening graft …
Epidemiology of febrile neutropenia
GH Lyman, NM Kuderer - Supportive cancer therapy, 2003 - Elsevier
Febrile neutropenia (FN) continues to represent a major cause of morbidity, mortality, and
cost in patients receiving cancer chemotherapy. The reported rates of FN vary considerably …
cost in patients receiving cancer chemotherapy. The reported rates of FN vary considerably …